Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 8, 2026

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules
04:24

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

Published on: June 16, 2023

Metrics for antibody therapeutics development.

Janice M Reichert

    Mabs
    |October 9, 2010
    PubMed
    Summary

    Genetic engineering produces monoclonal antibodies (mAbs) and alternative antibody formats for drug development. Analysis of over 600 therapeutic mAbs provides insights into clinical development metrics.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges.

    Cell·2026
    Same author

    Antibodies to watch in 2026.

    mAbs·2026
    Same author

    Innovative antibody therapeutic development in China compared with the USA and Europe.

    Nature reviews. Drug discovery·2025
    Same author

    YAbS: The Antibody Society's antibody therapeutics database.

    mAbs·2025
    Same author

    Antibodies to watch in 2025.

    mAbs·2024
    Same author

    The present and future of bispecific antibodies for cancer therapy.

    Nature reviews. Drug discovery·2024

    Area of Science:

    • Biotechnology and Pharmaceutical Sciences
    • Molecular Biology and Genetic Engineering

    Background:

    • Monoclonal antibodies (mAbs) and alternative antibody formats are key therapeutic molecules.
    • Genetic and biological engineering techniques enable their production for pharmaceutical pipelines.

    Discussion:

    • Analysis of over 600 commercial therapeutic mAbs provides metrics on clinical study entry and development timelines.
    • The study offers context for evaluating ongoing and future mAb development programs.

    Key Insights:

    • Therapeutic antibody development is expanding, with increased use of supplemental marketing approvals.
    • Alternative antibody formats are gaining traction in clinical studies.

    Outlook:

    • The field of antibody therapeutics is dynamic, driven by innovation in engineering and broader clinical application.
    • Future development will likely see continued growth in both traditional mAbs and novel antibody formats.

    More Related Videos

    Laboratory Scale Production and Purification of a Therapeutic Antibody
    09:54

    Laboratory Scale Production and Purification of a Therapeutic Antibody

    Published on: January 24, 2017

    Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
    10:50

    Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

    Published on: May 1, 2019

    Related Experiment Videos

    Last Updated: Jun 8, 2026

    An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules
    04:24

    An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules

    Published on: June 16, 2023

    Laboratory Scale Production and Purification of a Therapeutic Antibody
    09:54

    Laboratory Scale Production and Purification of a Therapeutic Antibody

    Published on: January 24, 2017

    Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
    10:50

    Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

    Published on: May 1, 2019